Legal Representation
Attorney
Peter G. Byrne, Esq.
USPTO Deadlines
Next Deadline
670 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-05-18)
Due Date
May 18, 2027
Grace Period Ends
November 18, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
41 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 20, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 20, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jun 20, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 20, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 20, 2024 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Jun 20, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Aug 2, 2022 | A7OK | O | AMENDMENT UNDER SECTION 7 - PROCESSED | Loading... |
| Aug 2, 2022 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Feb 24, 2022 | ES7R | I | TEAS SECTION 7 REQUEST RECEIVED | Loading... |
| Feb 16, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 16, 2022 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Feb 16, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Feb 16, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| May 18, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 13, 2021 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Apr 12, 2021 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Mar 29, 2021 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Mar 25, 2021 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Mar 25, 2021 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Sep 30, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 28, 2020 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Sep 28, 2020 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Sep 28, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 22, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 22, 2020 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
| Feb 21, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 21, 2020 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Feb 21, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jan 22, 2020 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jan 22, 2020 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Jan 22, 2020 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Jan 22, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 1, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 6, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 6, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 17, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 24, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 13, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 24, 2019 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| May 23, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 11, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals and medicines for the treatment of metabolic diseases and disorders, including obesity [, diabetes, metabolic syndrome and cachexia, and gastrointestinal diseases and disorders, including gastroparesis, post-operative ileus, chronic constipation, and inflammatory bowel disease ]
First Use Anywhere:
Mar 1, 2021
First Use in Commerce:
Mar 1, 2021
Additional Information
Color Claim
Color is not claimed as a feature of the mark.
Other
In the statement, line 5 "diabetes, metabolic syndrome and cachexia, and" is deleted; lines 6 and 7 is deleted.
Classification
International Classes
005